These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 26247403)
21. Lentivirus-Mediated RNAi silencing targeting ERCC1 reverses cisplatin resistance in cisplatin-resistant ovarian carcinoma cell line. Du P; Zhang X; Liu H; Chen L DNA Cell Biol; 2015 Jul; 34(7):497-502. PubMed ID: 25941922 [TBL] [Abstract][Full Text] [Related]
22. Targeting HMGB1 inhibits ovarian cancer growth and metastasis by lentivirus-mediated RNA interference. Chen J; Liu X; Zhang J; Zhao Y J Cell Physiol; 2012 Nov; 227(11):3629-38. PubMed ID: 22331597 [TBL] [Abstract][Full Text] [Related]
23. Lysosomal transmembrane protein LAPTM4B promotes autophagy and tolerance to metabolic stress in cancer cells. Li Y; Zhang Q; Tian R; Wang Q; Zhao JJ; Iglehart JD; Wang ZC; Richardson AL Cancer Res; 2011 Dec; 71(24):7481-9. PubMed ID: 22037872 [TBL] [Abstract][Full Text] [Related]
24. Lentivirus-mediated SMO RNA interference inhibits SMO expression and cell proliferation, and affects the cell cycle in LNCaP and PC3 cancer cell lines. Yang B; Sun HY; Chen WH; Wen JL; Shi XT; Wang YM Asian J Androl; 2010 Mar; 12(2):196-202. PubMed ID: 20023691 [TBL] [Abstract][Full Text] [Related]
25. [Inhibition of ovarian cancer growth by small interfering RNA targeting X-linked inhibitor of apoptosis gene]. Ma JJ; Chen BL; Xin XY Zhonghua Fu Chan Ke Za Zhi; 2007 Feb; 42(2):124-8. PubMed ID: 17442189 [TBL] [Abstract][Full Text] [Related]
26. Tao D; Liang J; Pan Y; Zhou Y; Feng Y; Zhang L; Xu J; Wang H; He P; Yao J; Zhao Y; Ning Q; Wang W; Jiang W; Zheng J; Wu X J Breast Cancer; 2019 Sep; 22(3):375-386. PubMed ID: 31598338 [TBL] [Abstract][Full Text] [Related]
27. Inhibitory effect of small interfering RNA targeting insulin-like growth factor-I receptor in ovarian cancer OVCAR3 cells. An Y; Cai Y; Guan Y; Cai L; Yang Y; Feng X; Zheng J Cancer Biother Radiopharm; 2010 Oct; 25(5):545-52. PubMed ID: 20950153 [TBL] [Abstract][Full Text] [Related]
28. Association of lysosomal protein transmembrane 4 beta gene polymorphism with pancreatic carcinoma susceptibility in the Chinese population. Wang B; Wang S; Liang G; Xu J; Zhou R; Zhang Q Tumour Biol; 2017 Jun; 39(6):1010428317705518. PubMed ID: 28618967 [TBL] [Abstract][Full Text] [Related]
29. Knockdown of UHRF1 by lentivirus-mediated shRNA inhibits ovarian cancer cell growth. Yan F; Shao LJ; Hu XY Asian Pac J Cancer Prev; 2015; 16(4):1343-8. PubMed ID: 25743796 [TBL] [Abstract][Full Text] [Related]
30. Effects of lentiviral-mediated Foxp1 and Foxq1 RNAi on the hepatocarcinoma cell. Qin J; Xu Y; Li X; Wu Y; Zhou J; Wang G; Chen L Exp Mol Pathol; 2014 Feb; 96(1):1-8. PubMed ID: 24211718 [TBL] [Abstract][Full Text] [Related]
31. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma]. Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of TMEM45A suppresses proliferation, induces cell cycle arrest and reduces cell invasion in human ovarian cancer cells. Guo J; Chen L; Luo N; Yang W; Qu X; Cheng Z Oncol Rep; 2015 Jun; 33(6):3124-30. PubMed ID: 25872785 [TBL] [Abstract][Full Text] [Related]
33. The Transcription Factor AP4 Promotes Oncogenic Phenotypes and Cisplatin Resistance by Regulating Wang L; Meng Y; Xu JJ; Zhang QY Mol Cancer Res; 2018 May; 16(5):857-868. PubMed ID: 29378908 [TBL] [Abstract][Full Text] [Related]
34. [Effects of the novel gene, LAPTM4B, highly expression in hepatocellular carcinoma on cell proliferation and tumorigenesis of NIH3T3 cells]. He J; Shao G; Zhou R Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Aug; 35(4):348-52. PubMed ID: 12947546 [TBL] [Abstract][Full Text] [Related]
35. [Construction of a lentiviral vector for RNA interference of PRL-3 gene and its stable expression in SW480 cells]. Liu YH; Li JM; Zhou J; Ding YQ Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):509-12. PubMed ID: 18495578 [TBL] [Abstract][Full Text] [Related]
36. miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression. Zhang H; Qi S; Zhang T; Wang A; Liu R; Guo J; Wang Y; Xu Y Oncotarget; 2015 Mar; 6(8):6092-104. PubMed ID: 25714029 [TBL] [Abstract][Full Text] [Related]
37. Lysosome-associated protein transmembrane-4β-35 is a novel independent prognostic factor in small cell lung cancer. Qiao M; Hu G Tumour Biol; 2015 Sep; 36(10):7493-9. PubMed ID: 25910706 [TBL] [Abstract][Full Text] [Related]
38. Overexpression of LAPTM4B promotes growth of gallbladder carcinoma cells in vitro. Zhou L; He XD; Yu JC; Zhou RL; Yang H; Qu Q; Rui JA Am J Surg; 2010 Apr; 199(4):515-21. PubMed ID: 19954766 [TBL] [Abstract][Full Text] [Related]
39. Effects of lentivirus-mediated RNAi knockdown of NEDD9 on human lung adenocarcinoma cells in vitro and in vivo. Chang JX; Gao F; Zhao GQ; Zhang GJ Oncol Rep; 2014 Oct; 32(4):1543-9. PubMed ID: 25051398 [TBL] [Abstract][Full Text] [Related]
40. Molecular cloning and characterization of LAPTM4B, a novel gene upregulated in hepatocellular carcinoma. Shao GZ; Zhou RL; Zhang QY; Zhang Y; Liu JJ; Rui JA; Wei X; Ye DX Oncogene; 2003 Aug; 22(32):5060-9. PubMed ID: 12902989 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]